Analyze Diet
Veterinary research communications2026; 50(6); 606; doi: 10.1007/s11259-026-11548-y

Etiological and immunological aspects of equine hoof canker.

Abstract: Chronic equine proliferative pododermatitis (canker) is a hypertrophic hoof disease characterized by excessive proliferation of horn-producing tissues resulting from dyskeratosis of keratinocytes. Since its etiology remains unknown, this study investigated potential etiological agents and evaluated biochemical and immunological profiles. Ten horses with hoof canker and ten healthy controls of the Norik of Muran breed were included. Dermatophytes and bovine papillomavirus 1 and 2 (BPV 1/2) were not detected. Candida glabrata was the most frequently identified species in both affected and healthy groups. In horses with canker, Aspergillus fumigatus, Mucor spp., and Trichosporon spp. were also detected. Biochemical analysis showed significantly higher creatine kinase myoglobin binding activity in affected horses compared to controls (12.58 ± 5.86 vs. 4.11 ± 1.57; p < 0.01), with a slight increase in aspartate aminotransferase activity. Principal component analysis revealed substantial overlap between healthy and affected groups. Immunologically, monocyte phagocytic activity was significantly reduced in affected horses (83.78% ± 3.40 vs. 90.26% ± 2.88; p < 0.001). Affected horses had increased CD4 (Th) lymphocyte counts and a higher CD4:CD8 ratio (p < 0.01), along with higher IgM B lymphocyte levels (27.20% ± 8.23 vs. 18.51% ± 4.53; p < 0.05). Serum IgG levels were also significantly elevated (11.15 ± 3.42 vs. 5.88 ± 1.91 mg/mL; p < 0.001). These results indicate stimulation of adaptive cellular and humoral immune responses in canker-affected horses. However, the lack of consistent pathogen detection suggests that the precise etiology of hoof canker remains unresolved and requires further investigation.
Publication Date: 2026-09-29 PubMed ID: 42809149PubMed Central: 3300549DOI: 10.1007/s11259-026-11548-yGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigates the causes and immune system changes in horses affected by chronic hoof canker, a proliferative disease of the hoof.
  • It compares fungal presence, biochemical markers, and immune parameters between horses with canker and healthy controls to better understand the disease’s etiology and immune response.

Background

  • Equine hoof canker, or chronic proliferative pododermatitis, is characterized by abnormal thickening of the hoof’s horn-producing layers due to keratinocyte dyskeratosis.
  • The exact cause of this disease is unknown, which complicates diagnosis and treatment.

Study Design and Sample

  • The study included 10 horses diagnosed with hoof canker and 10 healthy control horses, all from the Norik of Muran breed.
  • Researchers aimed to identify potential infectious agents and evaluate biochemical and immunological characteristics associated with the disease.

Etiological Findings

  • Tests did not detect common dermatophytes (fungi causing skin infections) nor bovine papillomavirus types 1 or 2 (BPV 1/2), which could have been potential causes.
  • Candida glabrata, a yeast, was the most frequently found organism in both affected and healthy horses, indicating it may commonly colonize hooves without necessarily causing disease.
  • Additional fungi such as Aspergillus fumigatus, Mucor species, and Trichosporon species were detected only in horses with canker, suggesting a possible association but not definitive causation.

Biochemical Analysis

  • Creatine kinase myoglobin binding activity (a marker often linked to muscle damage or stress) was significantly higher in horses with canker, indicating tissue stress or damage related to the condition.
  • Aspartate aminotransferase (AST), an enzyme related to cellular injury, showed a slight but not significant increase in affected horses.
  • Principal component analysis, a method to visualize differences, showed considerable overlap between healthy and affected groups, indicating no clear biochemical profile differentiating the groups.

Immunological Findings

  • Monocyte phagocytic activity (the capability of immune cells to engulf pathogens) was significantly reduced in horses with hoof canker, indicating impaired innate immune function.
  • Affected horses exhibited increased counts of CD4+ T-helper lymphocytes and a higher CD4:CD8 ratio, suggesting stimulation of adaptive cellular immunity.
  • Levels of IgM-producing B lymphocytes were elevated, along with significantly increased serum IgG antibody concentrations, highlighting an activated humoral (antibody-mediated) immune response.

Conclusions

  • Although certain fungi were detected more frequently in affected horses, the absence of consistent pathogens indicates no definitive infectious cause identified.
  • The disease involves a complex immune response, including both cellular and humoral immunity, possibly reacting to tissue damage or a persistent stimulus.
  • Biochemical changes support ongoing tissue alteration but do not provide a clear diagnostic marker for hoof canker.
  • Further research is needed to clarify the exact cause and pathogenesis of equine hoof canker to improve diagnosis and treatment strategies.

Cite This Article

APA
Styková E, Mudroňová D, Gancarčíková S, Žert Z, Kačírová J, Valocký I. (2026). Etiological and immunological aspects of equine hoof canker. Vet Res Commun, 50(6), 606. https://doi.org/10.1007/s11259-026-11548-y

Publication

ISSN: 1573-7446
NlmUniqueID: 8100520
Country: Switzerland
Language: English
Volume: 50
Issue: 6
PII: 606

Researcher Affiliations

Styková, Eva
  • Clinic of Horses, University Veterinary Hospital, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81, Košice, Slovak Republic.
Mudroňová, Dagmar
  • Department of Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81, Košice, Slovak Republic.
Gancarčíková, Soňa
  • Department of Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81, Košice, Slovak Republic.
Žert, Zdeněk
  • Clinic of Horses, University Veterinary Hospital, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81, Košice, Slovak Republic.
Kačírová, Jana
  • Institute of Plant Genetics and Biotechnology, Plant Science and Biodiversity Centre, Slovak Academy of Sciences, Akademická 2, 950 07, Nitra, Slovak Republic. jana.kacirova@savba.sk.
Valocký, Igor
  • Clinic of Horses, University Veterinary Hospital, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81, Košice, Slovak Republic.

MeSH Terms

  • Animals
  • Horses
  • Horse Diseases / immunology
  • Horse Diseases / microbiology
  • Horse Diseases / etiology
  • Foot Diseases / veterinary
  • Foot Diseases / immunology
  • Foot Diseases / microbiology
  • Foot Diseases / etiology
  • Hoof and Claw / pathology
  • Hoof and Claw / microbiology
  • Hoof and Claw / immunology
  • Male
  • Female

Grant Funding

  • 1/0108/26 / Vedecká Grantová Agentúra MŠVVaŠ SR a SAV

Conflict of Interest Statement

Declarations. Ethics approval: This study was approved by the Ethics Committee of the University of Veterinary Medicine and Pharmacy in Košice, Slovak Republic (permit number EKVP/2022-14). The study was conducted in accordance with local legislation and institutional requirements. Competing interests: The authors declare no competing interests.

References

This article includes 50 references
  1. Alam MR, Akinyemi AO, Wang J, Howlader M, Farahani ME, Nur M, Zhang M, Gu L, Li Z. CD4CD8 double-positive T cells in immune disorders and cancer: prospects and hurdles in immunotherapy.. Autoimmun Rev 24:103757.
    doi: 10.1016/j.autrev.2025.103757pubmed: 39855286google scholar: lookup
  2. Apprich V, Licka T. Equine hoof canker: a clinical trial of topical cisplatin chemotherapy.. Vet Rec 172:238.
    doi: 10.1136/vr.101359pubmed: 23362179google scholar: lookup
  3. Apprich V, Licka T, Zipfl N, Tichy A, Gabriel C. Equine hoof canker: cell proliferation and morphology.. Vet Pathol 54:661–668.
    doi: 10.1177/0300985817695515pubmed: 28622496google scholar: lookup
  4. Apprich V, Licka T, Freiler S, Gabriel C. Equine hoof canker: bovine papillomavirus infection is not associated with impaired keratinocyte differentiation.. Vet Pathol 57:525–534.
    doi: 10.1177/0300985820921820pubmed: 32347169google scholar: lookup
  5. Argiroudis SA, Kent JE, Blackmore DJ. Observations on the isoenzymes of creatine kinase in equine serum and tissues.. Equine Vet J 14:317–321.
  6. Arsenijevic NN, Baskic D, Acimovic LD. Phagocytic activity of monocytes in patients with breast cancer at different clinical stages.. Breast Cancer Res 3(Suppl 1):A4.
    doi: 10.1186/bcr366pmc: 3300549google scholar: lookup
  7. Azzolini EFOT, Bastos SF, Barros RM. Chronic equine proliferative pododermatitis: case report.. Braz J Vet Res Anim Sci 56:e160249.
  8. Baxter GM, Stashak TS. Canker.. In: Baxter GM (ed) Adams and Stashak’s Lameness in Horses, 6th edn. Wiley-Blackwell, Chichester and Ames, Iowa, pp 519–521.
  9. Brandt S, Schoster A, Tober R, Kainzbauer C, Burgstaller JP, Haralambus R, Steinborn R, Hinterhofer C, Stanek C. Consistent detection of bovine papillomavirus in lesions, intact skin and peripheral blood mononuclear cells of horses affected by hoof canker.. Equine Vet J 43:202–209.
  10. Brandt S, Apprich V, Hackl V, Tober R, Danzer M, Kainzbauer C, Gabriel C, Stanek C, Kofler J. Prevalence of bovine papillomavirus and Treponema DNA in bovine digital dermatitis lesions.. Vet Microbiol 148:161–167.
    doi: 10.1016/j.vetmic.2010.08.031pubmed: 20875931google scholar: lookup
  11. Burlikowska K, Bogusławska-Tryk M, Szymeczko R, Piotrowska A. Haematological and biochemical blood parameters in horses used for sport and recreation.. J Cent Eur Agric 16:370–382.
    doi: 10.5513/JCEA01/16.4.1634google scholar: lookup
  12. Connysson M, Jansson A. Starch allowance and muscle enzyme activity in healthy standardbred trotters trained by professional trainers.. J Anim Physiol Anim Nutr (Berl) 109:1130–1137.
    doi: 10.1111/jpn.14127pubmed: 40329464pmc: 12451409google scholar: lookup
  13. Czech A, Sembratowicz I, Wnuk E. Seasonal effects on haematological and biochemical blood parameters in cold-blooded mares.. J Anim Feed Sci 34:365–373.
    doi: 10.22358/jafs/200131/2025google scholar: lookup
  14. Dabareiner RM, Moyer WA, Carter GK. Trauma to the sole and wall.. In: Ross MW, Dyson SJ (eds) Diagnosis and Management of Lameness in the Horse, 2nd edn. Saunders, St. Louis, MO, pp 309-319.
  15. DeNotta S, McFarlane D. Immunosenescence and inflammaging in the aged horse.. Immun Ageing 20:2.
    doi: 10.1186/s12979-022-00325-5pubmed: 36609345pmc: 9817422google scholar: lookup
  16. Dietz O. Hufkrankheiten. .
  17. Gaire S, An J, Yang H, Lee KA, Dumre M, Lee EJ, Park SM, Joe EH. Systemic inflammation attenuates the repair of damaged brains through reduced phagocytic activity of monocytes infiltrating the brain. Mol Brain 17:47.
    doi: 10.1186/s13041-024-01116-3pubmed: 39075534pmc: 11288066google scholar: lookup
  18. Giers J, Bartel A, Kirsch K, Müller SF, Horstmann S, Gehlen H. Blood-based markers for skeletal and cardiac muscle function in eventing horses before and after cross-country rides and how they are influenced by plasma volume shift. Animals 13:3110.
    doi: 10.3390/ani13193110pubmed: 37835716pmc: 10572052google scholar: lookup
  19. Heimann M, Janda J, Sigurdardottir OG, Svansson V, Klukowska J, von Tscharner C, Doherr M, Broström H, Andersson LS, Einarsson S, Marti E, Torsteinsdottir S. Skin-infiltrating T cells and cytokine expression in Icelandic horses affected with insect bite hypersensitivity: a possible role for regulatory T cells. Vet Immunol Immunopathol 140:63–74.
    doi: 10.1016/j.vetimm.2010.11.016pubmed: 21168921google scholar: lookup
  20. Herbst AC, Reedy SE, Page AE, Horohov DW, Adams AA. Effect of aging on monocyte phagocytic and inflammatory functions, and on the ex vivo inflammatory responses to lipopolysaccharide, in horses. Vet Immunol Immunopathol 250:110459.
    doi: 10.1016/j.vetimm.2022.110459pubmed: 35863208google scholar: lookup
  21. Hohnadel K. Cardiac biomarkers. .
    doi: 10.1002/9781119357407.ch9google scholar: lookup
  22. Holmes CM, Wagner B. Characterization of nasal mucosal T cells in horses and their response to equine herpesvirus type 1. Viruses 16:1514.
    doi: 10.3390/v16101514pubmed: 39459849pmc: 11512333google scholar: lookup
  23. Jongbloets AM, van Sloet MM, Meeus PJ, Back W. Straalkanker: een (auto-)immuungemedieerde aandoening? [Equine exudative canker: an (auto-)immune disease?]. Tijdschr Diergeneeskd 130:106–109.
    pubmed: 15754903
  24. Keller M, Krehon S, Stanek C, Rosengarten R. Keratinopathogenic mould fungi and dermatophytes in healthy and diseased hooves of horses. Vet Rec 147:619–622.
    doi: 10.1136/vr.147.22.619pubmed: 11128074google scholar: lookup
  25. Kurapati R, Zubair M. Creatine kinase MB: diagnostic utility and limitations. .
  26. Liu BF, Miyata S, Kojima H, Uriuhara A, Kusunoki H, Suzuki K, Kasuga M. Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products. Diabetes 48:2074–2082.
    doi: 10.2337/diabetes.48.10.2074pubmed: 10512376google scholar: lookup
  27. Maksymovych I, Slivinska L, Buczek K, Staniec M, Milczak A. Blood biochemical parameters and associated interpretations in sport horses. Veterinary Sci Sci Educ New Dimension Nat Tech Sci 3:73.
  28. Marčeková P, Maďar M, Styková E, Kačírová J, Sondorová M, Mudroň P, Žert Z. The presence of Treponema spp. in equine hoof canker biopsies and skin samples from bovine digital dermatitis lesions. Microorganisms 9:2190.
    doi: 10.3390/microorganisms9112190pubmed: 34835315pmc: 8625648google scholar: lookup
  29. McFarlane D, Sellon DC, Gibbs SA. Age-related quantitative alterations in lymphocyte subsets and immunoglobulin isotypes in healthy horses. Am J Vet Res 62:1413–1417.
    doi: 10.2460/ajvr.2001.62.1413pubmed: 11560270google scholar: lookup
  30. Moe KK, Yano T, Kuwano A, Sasaki S, Misawa N. Detection of treponemes in canker lesions of horses by 16S rRNA clonal sequencing analysis. J Vet Med Sci 72:235–239.
    doi: 10.1292/jvms.09-0404pubmed: 19942809google scholar: lookup
  31. Nascimbeni M, Shin EC, Chiriboga L, Kleiner DE, Rehermann B. Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions.. Blood 104:478–486.
    doi: 10.1182/blood-2003-12-4395pubmed: 15044252google scholar: lookup
  32. Neira-Egea P, Alamar Malvoisin C, de la Cuesta-Torrado M, Bautista-Erler C, Vitale V, Jolly S, Cesarini C. Gastric candidiasis in five horses: a case series.. Microorganisms 13:1746.
  33. O’Grady SE. An overview of equine canker.. Am Farriers J 44(7):0274–6565.
  34. O’Grady SE, Madison JB. How to treat equine canker.. In: Proceedings of the 50th Annual Convention of the American Association of Equine Practitioners. AAEP, Lexington, KY, pp 202-205. Document No. P1426.1204..
  35. Oosterlinck M. Do’s and don’ts of treating hoof canker.. In: Abstracts European Veterinary Conference Voorjaarsdagen 2018, The Hague, The Netherlands.
  36. Oosterlinck M, Deneut K, Dumoulin M, Gasthuys F, Pille F. Retrospective study on 30 horses with chronic proliferative pododermatitis (canker).. Equine Vet Educ 23:466–471.
  37. Pađen L, Gomerčić T, Đuras M, Arbanasić H, Galov A. Hematological and serum biochemical reference values for the Posavina and Croatian coldblood horse breeds.. Acta Vet (Beogr) 64:200–212.
    doi: 10.2478/acve-2014-0019google scholar: lookup
  38. Pošivák J, Styková E, Novotný F, Valocký I, Noskovičová J, Tučková M, Bílek J, Korim P, Pošiváková T. Comparison of some biochemical and mineral indices among Norik breed Muráň Plain type and Hucul breed mares.. Acta Vet Brno 84:113–117.
    doi: 10.2754/avb201584020113google scholar: lookup
  39. Pretorius A, Van Kleef M, Van Wyngaardt W, Heath J. Virus-specific CD8⁺ T-cells detected in PBMC from horses vaccinated against African horse sickness virus.. Vet Immunol Immunopathol 146:81–86.
    doi: 10.1016/j.vetimm.2012.01.016pubmed: 22365333google scholar: lookup
  40. Prvanović Babić N, Kostelić A, Novak B, Šalamon D, Tariba B, Maćešić N, Karadjole T, Bačić G, Bedrica L. Reference values and influence of sex and age on hemogram and clinical biochemistry in protected and endangered Murinsulaner horses.. Vet arhiv 89:25–42.
    doi: 10.24099/vet.arhiv.0479google scholar: lookup
  41. Redding WR, O’Grady SE. Nonseptic diseases associated with the hoof complex: keratoma, white line disease, canker, and neoplasia.. Vet Clin North Am Equine Pract 28:407–421.
    doi: 10.1016/j.cveq.2012.06.006pubmed: 22981198google scholar: lookup
  42. Reinthaler B, Gabner S, Apprich V, Jehle M, Licka T. Effect of intra-arterial cisplatin on dorsal hoof wall tissue of isolated perfused equine limbs.. J Equine Vet Sci 150:105598.
    doi: 10.1016/j.jevs.2025.105598pubmed: 40339727google scholar: lookup
  43. Rival C, Mandal M, Cramton K, Qiao H, Arish M, Sun J, McCann JV, Dudley AC, Solga MD, Erdbrügger U, Erickson LD. B cells secrete functional antigen-specific IgG antibodies on extracellular vesicles.. Sci Rep 14:16970.
    doi: 10.1038/s41598-024-67912-ypubmed: 39043800pmc: 11266516google scholar: lookup
  44. Schrank K, Choi BK, Grund S, Moter A, Heuner K, Nattermann H, Göbel UB. Treponema brennaborense sp. nov., a novel spirochaete isolated from a dairy cow suffering from digital dermatitis.. Int J Syst Bacteriol 49:43–50.
    doi: 10.1099/00207713-49-1-43pubmed: 10028246google scholar: lookup
  45. Sykora S, Brandt S. Occurrence of Treponema DNA in equine hoof canker and normal hoof tissue.. Equine Vet J 47:627–630.
    doi: 10.1111/evj.12327pubmed: 25115798google scholar: lookup
  46. Twitchell EL, Hartman RA, Waxman SJ, Lescun TB, Miller MA. Pathology in practice. Coronary band dystrophy with proliferative pododermatitis.. J Am Vet Med Assoc 245:385–387.
    doi: 10.2460/javma.245.4.385pubmed: 25075820google scholar: lookup
  47. Vollrath JT, Klingebiel F, Bläsius FM, Greven J, Bolierakis E, Janicova A, Dunay IR, Hildebrand F, Marzi I, Relja B. Alterations of phagocytic activity and capacity in granulocytes and monocytes depend on the pathogen strain in porcine polytrauma.. Front Med (Lausanne) 8:645589.
    doi: 10.3389/fmed.2021.645589pubmed: 33889585pmc: 8055816google scholar: lookup
  48. Wang R, Lan C, Benlagha K, Camara NOS, Miller H, Kubo M, Heegaard S, Lee P, Yang L, Forsman H, Li X, Zhai Z, Liu C. The interaction of innate immune and adaptive immune system.. MedComm 5:e714.
    doi: 10.1002/mco2.714pubmed: 39286776pmc: 11401974google scholar: lookup
  49. Witkowska-Piłaszewicz O, Cywińska A, Michlik-Połczyńska K, Czopowicz M, Strzelec K, Biazik A, Parzeniecka-Jaworska M, Crisman M, Witkowski L. Variations in haematological and biochemical parameters in healthy ponies.. BMC Vet Res 17:38.
    doi: 10.1186/s12917-020-02741-5pubmed: 33468115pmc: 7814612google scholar: lookup
  50. Zhao J, Yang X, Auh SL, Kim KD, Tang H, Fu YX. Do adaptive immune cells suppress or activate innate immunity?. Trends Immunol 30:8–12.
    doi: 10.1016/j.it.2008.10.003pubmed: 19058755google scholar: lookup

Citations

This article has been cited 0 times.